The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

Fri, 05th Feb 2021 12:28

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Iconic Labs PLC - London-based media company - Appoints Sarah Dees as chief executive with immediate effect. Dees has a "wealth of management and fundraising experience" across a variety of sectors including financial technology, banking, live events and natural resources. "I am delighted to have the opportunity to lead Iconic Labs through the next phase of its development following the recent board changes. I will be prioritising early dialogue with OTT Holdings, alongside existing shareholders and lenders," Dees says.

On Monday, Iconic Labs received termination notices for management service agreements with Greencastle Capital for TheLondonEconomic, with management service agreement for JOE Media and Lovin' Media also terminated. Iconic Labs noted that the agreements represented the most significant proportion of Iconic's revenue to date. The termination notices cited the resignation of Iconic's senior management team, with John Quinlan, Liam Harrington and Sam Asante all resigning due to the failure of European High Growth Opportunities Securitization Fund to accept a revised settlement offer as well as outstanding issues with OTT Holdings Ltd and Alpha Blue Ocean.

----------

Tiziana Life Sciences PLC - London-based therapeutics for oncology, inflammation and infectious diseases - Appoints Thomas Adams as an executive director. Adams will assume the position of head of Drug Development with immediate effect, and his executive role will be to manage and oversee the company's pre-clinical and clinical drug development programmes and associated intellectual property. He is currently a director at Hepion Pharmaceuticals Inc.

----------

All Active Asset Capital Ltd - London-based firm seeking investment opportunities in the technology, software and artificial intelligence space - Intends to appoint Colin McQuade as a non-executive director. He is currently chief technology officer for BGL Group Ltd, a financial services business specialising in home and vehicle insurance, and prior to this was head of Change Technology at Barclays International.

----------

CPPGroup PLC - Leeds-based insurance and financial services company - Says Nick Cooper will be stepping down from the board and his position as a non-executive director at the end of the month to focus on his executive role as general counsel & company secretary of Johnson Matthey PLC.

----------

Prairie Mining Ltd - Poland-focused coal development firm - Notified that Todd Hannigan will resign as an alternate director to Tom Todd on Friday as he concentrates on other business and investment opportunities. Tom Todd will continue to serve as a non-executive director.

----------

Record PLC - specialist currency manager - Says Bob Noyen, chief investment officer of Record Currency Management Ltd, has decided to step down from the board of Record to focus more on his day-to-day role, though his responsibilities remain unchanged and he will continue to serve on the board of Record Currency Management.

----------

Sensyne Health PLC - Oxford, England-based clinical technology company - Appoints Hina Zaman as managing director of Healthcare Division and Martin Gouldstone as chief business officer of Life Sciences Division. Zaman joins Sensyne from Babylon Health, while Gouldstone joins from Syneos where he was global SVP Capital Solutions at Syneos One.

----------

Wishbone Gold PLC - precious metals trading and exploration company with assets in Australia - Hires David Hutchins as non-executive director effective Friday. He is currently chair of the FTSE Gold Mines Index Committee.

----------

Intertek Group PLC - London-based quality assurance provider - Hires Lynda Clarizio as a non-executive direct effective March 1. She served as president of US Media at Nielsen Holdings PLC and is currently a director of CDW Corp, Emerald Holding Inc, Adjust GmbH, OpenSlate and Resonate Networks Inc. Louise Makin will be stepping down from the board as a non-executive director on June 30 after serving for nine years.

----------

Digitalbox PLC - Bath, England-based digital media business that owns The Daily Mash and The Tab - Says Non-Executive Nigel Burton has resigned with immediate effect in order to pursue other opportunities.

----------

Gulf Marine Services PLC - Abu Dhabi-founded provider of self-propelled self-elevating support vessels for oil, gas and renewable energy industries - Says Hassan Heikal has agreed to take up the role of deputy chair, having joined the board in November 2020 as a non-executive director. Jyrki Koskelo is joining the group as an independent non-executive director, with immediate effect, bringing "extensive additional business advisory experience" to the board. Koskelo is currently a board member, and chair of the investment committee, of the Africa Agriculture & Trade Investment Fund

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Apr 2020 09:43

Tiziana Life Sciences files for patent on potential Covid-19 therapy

(Sharecast News) - Biotechnology company Tiziana Life Sciences has filed a provisional patent application on the combination of nanoparticle-Actinomycin D (NP-ACT D) with anti-interleukin-6 receptor monoclonal antibody (anti-IL-6R), it announced on Monday, as a potential therapy for the management of Covid-19 disease.

Read more
24 Apr 2020 18:39

Tiziana Life Sciences Acquires Potential Covid-19 Treatment Medication

Tiziana Life Sciences Acquires Potential Covid-19 Treatment Medication

Read more
9 Apr 2020 11:23

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

Read more
9 Apr 2020 09:12

Tiziana Life Sciences Shares Double On Covid-19 Treatment News

Tiziana Life Sciences Shares Double On Covid-19 Treatment News

Read more
9 Apr 2020 08:03

LONDON BRIEFING: Bank Of England Extends UK Government's Overdraft

LONDON BRIEFING: Bank Of England Extends UK Government's Overdraft

Read more
16 Mar 2020 17:48

Tiziana Raises USD10 Million To Help Fund Covid-19 Drug Development

Tiziana Raises USD10 Million To Help Fund Covid-19 Drug Development

Read more
12 Mar 2020 14:31

Tiziana Secures USD10 Million To Help Coronavirus Antibody Development

Tiziana Secures USD10 Million To Help Coronavirus Antibody Development

Read more
11 Mar 2020 12:15

Tiziana Life Sciences expediting development of Covid-19 drug

(Sharecast News) - Tiziana Life Sciences said on Wednesday that it is expediting the development of a drug that could help in the treatment of people infected with Covid-19.

Read more
11 Mar 2020 10:51

Tiziana Shares Skyrocket On Expedited Covid-19 Treatment Development

Tiziana Shares Skyrocket On Expedited Covid-19 Treatment Development

Read more
17 Feb 2020 14:30

Tiziana Life Sciences Proposes ADS Offering On Nasdaq

Tiziana Life Sciences Proposes ADS Offering On Nasdaq

Read more
4 Feb 2020 13:26

DIRECTOR DEALINGS SUMMARY: Biffa Municipal MD Sells 154,000 Shares

DIRECTOR DEALINGS SUMMARY: Biffa Municipal MD Sells 154,000 Shares

Read more
21 Jan 2020 16:09

Tiziana Life Sciences Hires OKYO Pharma Director MacRae As Non-Exec

Tiziana Life Sciences Hires OKYO Pharma Director MacRae As Non-Exec

Read more
14 Jan 2020 14:42

DIRECTOR DEALINGS: Tiziana Life Says Associate Of Chair Bought Shares

DIRECTOR DEALINGS: Tiziana Life Says Associate Of Chair Bought Shares

Read more
13 Jan 2020 11:07

Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda

Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda

Read more
9 Jan 2020 12:21

Tiziana Says Antibody Foralumab "Well Tolerated" At All Doses Tested

Tiziana Says Antibody Foralumab "Well Tolerated" At All Doses Tested

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.